Moving a compound from preclinical studies into humans has many scientific and ethical decision points and challenges that investigators, review boards, and regulatory agencies must address in readying a novel therapeutic for widespread use. Important considerations will be given to conflicts of interest that involve both clinical investigators and institutions that conduct clinical studies. This course will overview the system of checkpoints, and address the larger issue of ethics.
Course Component